Search research articles
Contact Us
Filters
Showing results (21-30 of 262) with videos related to
Page
of 27
Sort By:
Annals of the Rheumatic Diseases
|
April 18, 2025
Response to the correspondence on "CD19-CAR T-cell therapy induces deep tissue depletion of B cells"
Carlo Tur, Markus Eckstein, Georg Schett, et al.
Aktuelle Urologie
|
January 22, 2026
[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]
Gunhild von Amsberg, Arndt Hartmann, Markus Eckstein, et al.
European Urology
|
February 5, 2019
Re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40
Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, et al.
Pathologie (Heidelberg, Germany)
|
August 7, 2024
[Muscle-invasive and metastatic urothelial carcinoma of the urinary bladder : Current state of histopathologic, molecular, and immunologic prognostic and predictive factors]
Simone Bertz, Veronika Bahlinger, Fabienne Lange, et al.
European Urology
|
March 14, 2024
Re: Assessment of PD-L1, TROP2, and NECTIN-4 Expression in Penile Squamous Cell Carcinoma
Johannes Linxweiler, Niklas Klümper, Jan Mink, et al.
Medical Image Analysis
|
December 2, 2025
Spatial transcriptomics expression prediction from histopathology based on cross-modal mask reconstruction and contrastive learning
Junzhuo Liu, Markus Eckstein, Zhixiang Wang, et al.
European Urology
|
May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer
Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
Urologic Oncology
|
February 22, 2026
The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review
August Fiegl, Jan Mink, Kerstin Junker, et al.
Cancers
|
April 3, 2021
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
Antonio Lopez-Beltran, Fernando López-Rios, Rodolfo Montironi, et al.
European Urology
|
April 10, 2024
Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
Niklas Klümper, Francisco E Vera-Badillo, Markus Eckstein, et al.
Page
of 27
Search research articles
Search
Showing results (21-30 of 262) with videos related to
Sort By:
Page
of 27
Annals of the Rheumatic Diseases
|
April 18, 2025
Response to the correspondence on "CD19-CAR T-cell therapy induces deep tissue depletion of B cells"
Carlo Tur, Markus Eckstein, Georg Schett, et al.
Aktuelle Urologie
|
January 22, 2026
[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]
Gunhild von Amsberg, Arndt Hartmann, Markus Eckstein, et al.
European Urology
|
February 5, 2019
Re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40
Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, et al.
Pathologie (Heidelberg, Germany)
|
August 7, 2024
[Muscle-invasive and metastatic urothelial carcinoma of the urinary bladder : Current state of histopathologic, molecular, and immunologic prognostic and predictive factors]
Simone Bertz, Veronika Bahlinger, Fabienne Lange, et al.
European Urology
|
March 14, 2024
Re: Assessment of PD-L1, TROP2, and NECTIN-4 Expression in Penile Squamous Cell Carcinoma
Johannes Linxweiler, Niklas Klümper, Jan Mink, et al.
Medical Image Analysis
|
December 2, 2025
Spatial transcriptomics expression prediction from histopathology based on cross-modal mask reconstruction and contrastive learning
Junzhuo Liu, Markus Eckstein, Zhixiang Wang, et al.
European Urology
|
May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer
Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
Urologic Oncology
|
February 22, 2026
The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review
August Fiegl, Jan Mink, Kerstin Junker, et al.
Cancers
|
April 3, 2021
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
Antonio Lopez-Beltran, Fernando López-Rios, Rodolfo Montironi, et al.
European Urology
|
April 10, 2024
Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
Niklas Klümper, Francisco E Vera-Badillo, Markus Eckstein, et al.
Page
of 27